MCID: CTR001
MIFTS: 60

Citrullinemia malady

Categories: Genetic diseases, Rare diseases, Metabolic diseases

Aliases & Classifications for Citrullinemia

About this section

Aliases & Descriptions for Citrullinemia:

Name: Citrullinemia 51 11 25 12 49 38 13 67
Ass Deficiency 11 23 47 24 53 69
Argininosuccinate Synthetase Deficiency 23 47 24 53 69
Citrullinemia Type I 23 47 24 53 69
Classic Citrullinemia 23 47 53 69
Ctln1 23 24 53 69
Argininosuccinic Acid Synthetase Deficiency 23 24 53
Citrullinuria 47 25 69
Citrullinemia, Classic 51 24
Citrullinemia Type 1 53 26
 
Citrullinemia 1 47 69
Ctnl1 47 67
Cit 25 2
Argininosuccinic Acid Synthetase Deficiency, Complete 67
Deficiency of Citrulline-Aspartate Ligase 11
Argininosuccinic Acid Synthase Deficiency 53
Argininosuccinate Synthase Deficiency 53
Citrullinemia Classical 49
Classical Citrullinemia 24

Characteristics:

Orphanet epidemiological data:

53
ass deficiency:
Inheritance: Autosomal recessive; Prevalence: 1-9/100000 (Europe); Age of onset: All ages

HPO:

63
citrullinemia:
Inheritance: autosomal recessive inheritance
Onset and clinical course: neonatal onset, phenotypic variability

Classifications:



External Ids:

OMIM51 215700
Disease Ontology11 DOID:9273
ICD1029 E72.23
MeSH38 D020159
NCIt44 C84639
Orphanet53 ORPHA247525
ICD10 via Orphanet30 E72.2
MedGen36 C0175683

Summaries for Citrullinemia

About this section
CDC:2 The Countermeasure Inventory Tracking (CIT) Dashboard is a national system used by federal and state emergency response authorities, which provides the ability to track the availability of critical medical and non-medical countermeasures within the commercial drug sector as well as state public health agencies during public health emergencies. By receiving timely data on inventory and distribution of key pharmaceuticals and medical supplies, CDC will be better prepared to ensure that critical countermeasures reach vulnerable populations during an emergency. Voluntary participation of pharmaceutical and medical equipment suppliers is essential to successful planning for events that may impact our national future.

MalaCards based summary: Citrullinemia, also known as ass deficiency, is related to citrullinemia, adult-onset type ii and citrullinemia, type ii, neonatal-onset, and has symptoms including stroke, irritability and intellectual disability. An important gene associated with Citrullinemia is ASS1 (Argininosuccinate Synthase 1), and among its related pathways are Alanine, aspartate and glutamate metabolism and Arginine biosynthesis. Affiliated tissues include liver, bone and bone marrow, and related mouse phenotypes are integument and growth/size/body region.

UniProtKB/Swiss-Prot:69 Citrullinemia 1: The classic form of citrullinemia, an autosomal recessive disease characterized primarily by elevated serum and urine citrulline levels. Ammonia intoxication is another manifestation. It is a disorder of the urea cycle, usually manifesting in the first few days of life. Affected infants appear normal at birth, but as ammonia builds up in the body they present symptoms such as lethargy, poor feeding, vomiting, seizures and loss of consciousness. Less commonly, a milder form can develop later in childhood or adulthood.

Genetics Home Reference:25 Citrullinemia is an inherited disorder that causes ammonia and other toxic substances to accumulate in the blood. Two forms of citrullinemia have been described; they have different signs and symptoms and are caused by mutations in different genes.

Disease Ontology:11 An urea cycle disorder that involves the accumulation of ammonia in the blood.

NIH Rare Diseases:47 Citrullinemia type I is an inherited disorder that causes ammonia and other toxic substances to accumulate in the blood. This condition, also known as classic citrullinemia, belongs to a class of genetic diseases called urea cycle disorders. In most cases, the condition becomes evident in the first few days of life. Affected infants typically appear normal at birth, but as ammonia builds up in the body they experience a progressive lack of energy (lethargy), poor feeding, vomiting, seizures, and loss of consciousness. Citrullinemia type I is caused by mutations in the ASS1 gene. It is inherited in an autosomal recessive pattern. Last updated: 4/20/2010

Wikipedia:70 Citrullinemia is an autosomal recessive urea cycle disorder that causes ammonia and other toxic... more...

Description from OMIM:51 215700

GeneReviews for NBK1458

Related Diseases for Citrullinemia

About this section

Diseases in the Citrullinemia family:

Citrullinemia, Adult-Onset Type Ii Adult-Onset Citrullinemia Type I

Diseases related to Citrullinemia via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 47)
idRelated DiseaseScoreTop Affiliating Genes
1citrullinemia, adult-onset type ii12.3
2citrullinemia, type ii, neonatal-onset12.2
3acute neonatal citrullinemia type i11.9
4adult-onset citrullinemia type i11.9
5argininosuccinic aciduria11.6
6carbamoylphosphate synthetase i deficiency10.8
7argininemia10.8
8ornithine transcarbamylase deficiency10.8
9autosomal genetic disease10.0ASS1, SLC25A13
10pancreatitis9.9
11hepatocellular carcinoma9.9
12hyperammonemia9.9
13propionicacidemia9.8ASS1, OTC
14hepatitis9.8
15epilepsy9.8
16encephalopathy9.8
17atrial fibrillation, familial, 49.8PC, SLC25A13
18saccharopinuria9.8OTC, PC
19fga-related congenital afibrinogenemia9.7PPARA, SLC25A13
20deafness, autosomal dominant 109.7ASL, ASS1, OTC
21schizophrenia9.6
22pyruvate carboxylase deficiency9.6
23hypertriglyceridemia9.6
24liver cirrhosis9.6
25liver disease9.6
26neutropenia9.6
27somatostatinoma9.6
28urea cycle disorder9.6
29hypertrophic pyloric stenosis9.6
30pyloric stenosis9.6
31papilledema9.6
32status epilepticus9.6
33duodenitis9.6
34fatty liver disease9.6
35encephalitis9.6
36nonalcoholic steatohepatitis9.6
37pili torti9.6
38transposition of the great arteries9.6
39acth deficiency9.6
40postpartum psychosis9.6
41orotic aciduria9.6ASL, ASS1, OTC
42shwachman-diamond syndrome9.6ASL, ASS1, OTC
43chromosome xp21 deletion syndrome9.6ASL, ASS1, OTC
44atrophic glossitis9.6ASS1, OTC, PC
45wagr syndrome9.3ASL, ASS1, OTC, SLC25A13
46femoral neuropathy9.2PC, PPARA
47leukemia, chronic lymphocytic 38.0ASL, ASS1, OTC, PC, PPARA, SLC25A13

Graphical network of the top 20 diseases related to Citrullinemia:



Diseases related to citrullinemia

Symptoms for Citrullinemia

About this section

Symptoms by clinical synopsis from OMIM:

215700

Clinical features from OMIM:

215700

Human phenotypes related to Citrullinemia:

 63 (show all 19)
id Description HPO Frequency HPO Source Accession
1 stroke63 rare (5%) HP:0001297
2 irritability63 HP:0000737
3 intellectual disability63 HP:0001249
4 seizures63 HP:0001250
5 ataxia63 HP:0001251
6 lethargy63 HP:0001254
7 coma63 HP:0001259
8 global developmental delay63 HP:0001263
9 failure to thrive63 HP:0001508
10 respiratory alkalosis63 HP:0001950
11 episodic ammonia intoxication63 HP:0001951
12 hyperammonemia63 HP:0001987
13 vomiting63 HP:0002013
14 protein avoidance63 HP:0002038
15 cerebral edema63 HP:0002181
16 hepatomegaly63 HP:0002240
17 hyperglutaminemia63 HP:0003217
18 oroticaciduria63 HP:0003218
19 hypoargininemia63 HP:0005961

UMLS symptoms related to Citrullinemia:


ataxia, hepatomegaly, lethargy, seizures, vomiting

Drugs & Therapeutics for Citrullinemia

About this section

Drugs for Citrullinemia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 17)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Acetohydroxamic AcidapprovedPhase 1, Phase 21546-88-31990
Synonyms:
00507_FLUKA
159034_ALDRICH
546-88-3
A0051
AC1L1COH
AC1Q1L7G
AHA
AI3-62232
AKOS000172340
Acetamide, N-hydroxy- (9CI)
Acethydroxamic acid
Acethydroxamsaeure
Acethydroxamsaeure [German]
Acethydroxamsaure
Acetic acid, oxime
Acetohydroxamate
Acetohydroxamic acid
Acetohydroxamic acid (USP/INN)
Acetohydroxamic acid [USAN:INN]
Acetohydroximic acid
Acetyl hydroxyamino
Acetylhydroxamic acid
Acide acetohydroxamique
Acide acetohydroxamique [French]
Acido acetohidroxamico
Acido acetohidroxamico [Spanish]
Acidum acetohydroxamicum
Acidum acetohydroxamicum [Latin]
BSPBio_001790
C06808
CCRIS 1730
CHEBI:27777
CHEBI:49029
CHEMBL734
CID1990
Cetohyroxamic acid
D00220
DB00551
DivK1c_000821
EINECS 208-913-8
HAE
HMS1920A07
HMS2091G07
 
HMS502J03
HSDB 3585
I08-0057
IDI1_000821
KBio1_000821
KBio2_000360
KBio2_002928
KBio2_005496
KBio3_001290
KBioGR_000556
KBioSS_000360
LS-13067
Lithostat
Lithostat (TN)
MLS001076662
Methylhydroxamic acid
MolPort-001-769-610
N-Acetyl hydroxyacetamide
N-Acetylhydroxylamine
N-Hydroxyacetamide
N-hydroxyacetimidic acid
N-hydroxyethanimidic acid
NCGC00094576-01
NCGC00094576-02
NCGC00094576-03
NINDS_000821
NSC 176136
NSC176136
NSC5073
Prestwick_38
S14-0751
SMR000499570
SPBio_000098
SPECTRUM1500103
Spectrum2_000109
Spectrum3_000285
Spectrum4_000138
Spectrum5_000812
Spectrum_000020
UNII-4RZ82L2GY5
WLN: QMV1
ZINC04658603
acetohydroxamic acid
cetohyroxamic acid
sJX`HLdmMAH`
2HematinicsPhase 21630
3Liver ExtractsPhase 2, Phase 13868
4
OrnithineNutraceuticalPhase 2, Phase 1693184-13-26262, 389
Synonyms:
(+)-S-Ornithine
(+/-)-2,5-Diaminopentanoic acid monohydrochloride
(S)-2,5-Diaminopentanoate
(S)-2,5-Diaminopentanoic acid
(S)-Ornithine
(S)-a,D-Diaminovalerate
(S)-a,D-Diaminovaleric acid
2,5-Diaminopentanoic acid hydrochloride
5-Amino-L-Norvaline
D -2,5-Diaminopentanoic acid
D-Ornithine
DL -2,5-Diaminopentanoic acid
DL-ornithine
DL-ornithine HCL
DL-ornithine monohydrochloride
DL-ornithine, hydrochloride
 
L -2,5-Diaminopentanoic acid
L-(-)-Ornithine
L-Ornithine
L-Ornithine hydrochloride
L-Ornithine hydrochloride (van)
L-Ornithine monohydrochloride
L-Ornithine, monohydrochloride
L-Ornithine-carboxy-14C hydrochloride
MonohydrochlorideDL-Ornithine
Monohydrochloridel-Ornithine
Ornithine DL-form HCL
Ornithine DL-form monohydrochloride
Ornithine hydrochloride
Ornithine hydrochloride (van)
Ornithine monohydrochloride
Ornithine, hydrochloride (1:1)
Ornithine, monohydrochloride
Poly-L-ornithine hydrochloride
5
Nitric Oxideapproved59910102-43-9145068
Synonyms:
(.)NO
(NO)(.)
10102-43-9
14332-28-6
295566_ALDRICH
51005-20-0
51005-21-1
53851-19-7
90452-29-2
AC1L1ADQ
AC1L3QHF
AC1Q6QZ0
AR-1K7463
Bioxyde d'azote
Bioxyde d'azote [French]
C00533
CCRIS 4319
CHEMBL1200689
CHEMBL1234765
CID145068
CID945
D00074
D009569
DB00435
EDRF
EINECS 233-271-0
Endogenous Nitrate Vasodilator
Endothelium-Derived Nitric Oxide
HNO
HSDB 1246
INOmax
INOmax (TN)
LS-192158
LS-7547
MolPort-003-929-452
Mononitrogen monoxide
Monoxide, Mononitrogen
Monoxide, Nitrogen
Monoxido de nitrogeno
Monoxyde d'azote
NITRIC-OXIDE
NO
NO(.)
Nitrate Vasodilator, Endogenous
Nitric Oxide, Endothelium Derived
 
Nitric Oxide, Endothelium-Derived
Nitric oxide
Nitric oxide (JAN)
Nitric oxide 10% by volume or more
Nitric oxide trimer
Nitric oxide, compressed [UN1660] [Poison gas]
Nitric oxide, compressed [UN1660] [Poison gas]
Nitrogen monoxide
Nitrogen oxide
Nitrogen oxide (NO)
Nitrogen protoxide
Nitrosyl
Nitrosyl hydride
Nitrosyl hydride ((NO)H)
Nitrosyl radical
Nitroxide radical
Nitroxyl
OHM 11771
Oxide, Nitric
Oxido de nitrogeno(ii)
Oxido nitrico
Oxyde azotique
Oxyde nitrique
Oxyde nitrique [French]
RCRA waste no. P076
Stickmonoxyd
Stickmonoxyd [German]
Stickstoff(II)-oxid
Stickstoff(ii)-oxid
Stickstoffmonoxid
UN 1660
UN1660
UNII-31C4KY9ESH
Vasodilator, Endogenous Nitrate
[NO]
endothelium-derived relaxing factor
monoxido de nitrogeno
monoxyde d'azote
nitric oxide
nitrogen monooxide
nitrogen monoxide
nitrosyl
oxido de nitrogeno(II)
oxido nitrico
oxidonitrogen(.)
oxoazanyl
oxyde azotique
6Peripheral Nervous System Agents22776
7Vasodilator Agents3438
8Neurotransmitter Agents17734
9Respiratory System Agents4818
10Protective Agents7190
11Bronchodilator Agents2856
12Anti-Asthmatic Agents3369
13Antioxidants2928
14Endothelium-Dependent Relaxing Factors272
15Autonomic Agents9774
16Vaccines6428
17arginineNutraceutical408

Interventional clinical trials:

idNameStatusNCT IDPhase
1Human Heterologous Liver Cells for Infusion in Children With Urea Cycle DisordersCompletedNCT00718627Phase 2
2Pilot Study For Hypothermia Treatment In Hyperammonemic Encephalopathy In Neonates And Very Young InfantsCompletedNCT01624311Phase 2
3Urease Inhibitor Drug Treatment for Urea Cycle DisordersNot yet recruitingNCT02670889Phase 1, Phase 2
4Hepatocyte Transplantation for Liver Based Metabolic DisordersSuspendedNCT01345578Phase 1
5Citrulline Allo. Evaluation of Citrullinemia as a Marker of Bowel Damage After Allogeneic Bone Marrow Transplantation in ChildrenUnknown statusNCT00751452
6Nitric Oxide Flux and Ureagenesis in Argininosuccinate Synthetase Deficiency (ASSD)(Citrullinemia I)CompletedNCT01610089
7Microcirculation During Extracorporeal CirculationCompletedNCT01389947
8Neuroimaging and Neuropsychological Outcomes in Urea Cycle DisordersRecruitingNCT02935283
9The NIH UNI Study: Urea Cycle Disorders, Nutrition and ImmunityTerminatedNCT01421888

Search NIH Clinical Center for Citrullinemia


Cochrane evidence based reviews: citrullinemia

Genetic Tests for Citrullinemia

About this section

Genetic tests related to Citrullinemia:

id Genetic test Affiliating Genes
1 Citrullinemia Type I26 24 ASS1

Anatomical Context for Citrullinemia

About this section

MalaCards organs/tissues related to Citrullinemia:

35
Liver, Bone, Bone marrow, Testes, Brain, Skin

Animal Models for Citrullinemia or affiliated genes

About this section

MGI Mouse Phenotypes related to Citrullinemia:

40
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00107719.2ASL, ASS1, OTC, PPARA
2MP:00053788.8ASL, ASS1, OTC, PPARA, SLC25A13
3MP:00053767.9ASL, ASS1, OTC, PC, PPARA, SLC25A13
4MP:00107687.1ASL, ASS1, OTC, PC, PPARA, SLC25A13

Publications for Citrullinemia

About this section

Articles related to Citrullinemia:

(show top 50)    (show all 192)
idTitleAuthorsYear
1
Functional analysis of novel splicing and missense mutations identified in the ASS1 gene in classical citrullinemia patients. (25179242)
2014
2
Three cases of adult-onset type II citrullinemia treated with different therapies: Efficacy of sodium pyruvate and low-carbohydrate diet. (23701493)
2013
3
Citrullinemia type I and hypertrophic pyloric stenosis in a 1-month old male infant. (24765495)
2013
4
A 73-year-old patient with adult-onset type II citrullinemia successfully treated by sodium pyruvate and arginine. (23369404)
2013
5
Liver-directed adeno-associated virus serotype 8 gene transfer rescues a lethal murine model of citrullinemia type 1. (24131980)
2013
6
Auxiliary partial orthotopic liver transplantation for adult onset type II citrullinemia. (22066084)
2011
7
A case of adult-onset type II citrullinemia with comorbid epilepsy even after liver transplantation. (21204812)
2010
8
Possible mechanism for zonisamide-induced hyperammonemia in a child with citrullinemia type 1. (19584493)
2009
9
Citrulline and ammonia accumulating in citrullinemia reduces antioxidant capacity of rat brain in vitro. (16773471)
2006
10
Adult-onset type II citrullinemia and idiopathic neonatal hepatitis caused by citrin deficiency: involvement of the aspartate glutamate carrier for urea synthesis and maintenance of the urea cycle. (15050970)
2004
11
Feasibility of auxiliary partial orthotopic liver transplantation from living donors for patients with adult-onset type II citrullinemia. (15048800)
2004
12
Effectiveness of carbohydrate-restricted diet and arginine granules therapy for adult-onset type II citrullinemia: a case report of siblings showing homozygous SLC25A13 mutation with and without the disease. (12787807)
2003
13
Structure of the human argininosuccinate synthetase gene and an improved system for molecular diagnostics in patients with classical and mild citrullinemia. (11941481)
2002
14
Infantile citrullinemia caused by citrin deficiency with increased dibasic amino acids. (12409267)
2002
15
Improving the prenatal diagnosis of citrullinemia using citrulline/ornithine+arginine ratio in amniotic fluid. (12116302)
2002
16
Citrullinemia type II in a 64-year-old man with fluctuating serum citrulline levels. (11137523)
2001
17
High serum pancreatic secretory trypsin inhibitor before onset of type II citrullinemia. (11552040)
2001
18
Identification of two novel mutations in the SLC25A13 gene and detection of seven mutations in 102 patients with adult-onset type II citrullinemia. (11153906)
2000
19
The first successful prenatal diagnosis on a Korean family with citrullinemia. (11211875)
2000
20
Novel 67-bp insertional mutation in the ASS gene in a patient with citrullinemia. (10862106)
2000
21
An adult-onset case of argininosuccinate synthetase deficiency presenting with atypical citrullinemia. (10435367)
1999
22
Fulminant neonatal citrullinemia complicated by subarachnoid hemorrhage. (8869548)
1996
23
Mutations in argininosuccinate synthetase mRNA in Japanese patients, causing classical citrullinemia. (7825601)
1995
24
Impaired ketogenesis in patients with adult-type citrullinemia. (7926463)
1994
25
Mutations in argininosuccinate synthetase mRNA of Japanese patients, causing classical citrullinemia. (7977368)
1994
26
Generation of a mouse model for citrullinemia by targeted disruption of the argininosuccinate synthetase gene. (8197477)
1994
27
Management of neonatal citrullinemia. (8292188)
1993
28
Citrullinemia Type I (20301631)
1993
29
A search for the primary abnormality in adult-onset type II citrullinemia. (8105687)
1993
30
Glutamate and gamma-aminobutyric acid neurotransmitter systems in the acute phase of maple syrup urine disease and citrullinemia encephalopathies in newborn calves. (1352800)
1992
31
Heterogeneity of mutations in argininosuccinate synthetase causing human citrullinemia. (2358466)
1990
32
Molecular basis of enzyme abnormalities in urea cycle disorders. With special reference to citrullinemia and argininosuccinic aciduria. (3440446)
1987
33
Messenger RNA coding for argininosuccinate synthetase in citrullinemia. (3459354)
1986
34
Citrullinemia: quantitative deficiency of argininosuccinate synthetase in the liver. (3738904)
1986
35
Pili torti in association with citrullinemia. (3973120)
1985
36
The EEGs of infants with citrullinemia. (3996777)
1985
37
Papilledema in late-onset citrullinemia. (6696036)
1984
38
Citrullinemia presenting as uncontrollable epilepsy. (6486381)
1984
39
Citrullinemia: prenatal diagnosis of an affected fetus. (6823975)
1983
40
Diurnal fluctuation of blood ammonia levels in adult-type citrullinemia. (7202267)
1982
41
Enzymatic analysis of citrullinemia (12 cases) in Japan. (7164923)
1982
42
Variation in argininosuccinate synthetase activity in amniotic fluid cell cultures: implications for prenatal diagnosis of citrullinemia. (7318168)
1981
43
Qualitative and quantitative abnormalities of argininosuccinate synthetase in citrullinemia. (6784969)
1981
44
Lysine intolerance in a variant form of citrullinemia. (503639)
1979
45
Citrullinemia: phenotypic variations. (934749)
1976
46
Citrullinemia: enzymatic evidence for genetic heterogeneity. (1161343)
1975
47
Citrullinemia: investigation and treatment over a four-year period. (4842795)
1974
48
Citrullinemia: elevated serum citrulline levels in healthy siblings. (5451998)
1970
49
Citrullinemia. (5641790)
1968
50
Citrullinemia. A preliminary case report. (6015894)
1967

Variations for Citrullinemia

About this section

UniProtKB/Swiss-Prot genetic disease variations for Citrullinemia:

69 (show all 62)
id Symbol AA change Variation ID SNP ID
1ASS1p.Gly14SerVAR_000681rs121908636
2ASS1p.Ser18LeuVAR_000682rs121908643
3ASS1p.Arg86CysVAR_000683rs121908644
4ASS1p.Ala118ThrVAR_000684rs775305020
5ASS1p.Arg157HisVAR_000685rs121908637
6ASS1p.Ser180AsnVAR_000686rs121908638
7ASS1p.Ala192ValVAR_000687
8ASS1p.Arg272CysVAR_000688rs762387914
9ASS1p.Gly280ArgVAR_000689
10ASS1p.Arg304TrpVAR_000690rs121908642
11ASS1p.Gly324SerVAR_000691rs121908639
12ASS1p.Arg363LeuVAR_000692
13ASS1p.Arg363TrpVAR_000693rs121908640
14ASS1p.Gly390ArgVAR_000694rs121908641
15ASS1p.Cys19ArgVAR_015891
16ASS1p.Arg86HisVAR_015892rs575001023
17ASS1p.Arg95SerVAR_015893
18ASS1p.Pro96SerVAR_015894
19ASS1p.Gly117SerVAR_015895rs770944877
20ASS1p.Gly117AspVAR_015896
21ASS1p.Arg157CysVAR_015897rs770585183
22ASS1p.Trp179ArgVAR_015898rs121908646
23ASS1p.Glu191LysVAR_015899rs777828000
24ASS1p.Arg265HisVAR_015900rs398123131
25ASS1p.Val269MetVAR_015901rs370595480
26ASS1p.Glu283LysVAR_015902rs765338121
27ASS1p.Lys310ArgVAR_015903rs199751308
28ASS1p.Gly362ValVAR_015904rs121908647
29ASS1p.Glu270GlnVAR_016007rs775163147
30ASS1p.Arg279GlnVAR_016008rs371265106
31ASS1p.Lys310GlnVAR_016009rs121908648
32ASS1p.Arg363GlyVAR_016010
33ASS1p.Arg363GlnVAR_016011rs771937610
34ASS1p.Thr389IleVAR_016012
35ASS1p.Val69AlaVAR_016013rs771594651
36ASS1p.Arg108LeuVAR_016014rs35269064
37ASS1p.Thr119IleVAR_016015
38ASS1p.Gln40LeuVAR_058337
39ASS1p.Ser79ProVAR_058338
40ASS1p.Pro96HisVAR_058339
41ASS1p.Asp124AsnVAR_058340
42ASS1p.Arg127GlnVAR_058341rs201623252
43ASS1p.Arg127TrpVAR_058342rs771794639
44ASS1p.Leu160ProVAR_058343
45ASS1p.Tyr190AspVAR_058344
46ASS1p.Glu191GlnVAR_058345
47ASS1p.Ala202GluVAR_058346rs376371866
48ASS1p.Leu206ProVAR_058347
49ASS1p.Val263MetVAR_058348rs192838388
50ASS1p.Arg265CysVAR_058349rs148918985
51ASS1p.Lys277ThrVAR_058350
52ASS1p.Thr284IleVAR_058351
53ASS1p.Tyr291SerVAR_058352
54ASS1p.Asp296GlyVAR_058353
55ASS1p.Met302ValVAR_058354
56ASS1p.Arg307CysVAR_058355rs183276875
57ASS1p.Gly324ValVAR_058356
58ASS1p.Ser341PheVAR_058357
59ASS1p.Val345GlyVAR_058358
60ASS1p.Gly347ArgVAR_058359
61ASS1p.Tyr359AspVAR_058360
62ASS1p.Val141GlyVAR_072792

Clinvar genetic disease variations for Citrullinemia:

5 (show all 45)
id Gene Variation Type Significance SNP ID Assembly Location
1ASS1NM_000050.4(ASS1): c.1194-1G> CSNVLikely pathogenic, Pathogenicrs727503814GRCh37Chr 9, 133376362: 133376362
2ASS1NM_000050.4(ASS1): c.1138C> T (p.Gln380Ter)SNVLikely pathogenicrs786204460GRCh37Chr 9, 133374902: 133374902
3ASS1NM_000050.4(ASS1): c.892delG (p.Glu298Argfs)deletionLikely pathogenicrs770362721GRCh37Chr 9, 133364773: 133364773
4ASS1NM_000050.4(ASS1): c.1030C> T (p.Arg344Ter)SNVLikely pathogenic, Pathogenicrs786204537GRCh37Chr 9, 133370313: 133370313
5ASS1NM_000050.4(ASS1): c.450_451delCT (p.Phe150Leufs)deletionLikely pathogenicrs786204648GRCh38Chr 9, 130466754: 130466755
6ASS1NM_000050.4(ASS1): c.421-2A> GSNVPathogenicrs751930594GRCh37Chr 9, 133342110: 133342110
7ASS1NM_000050.4(ASS1): c.571G> A (p.Glu191Lys)SNVPathogenicrs777828000GRCh37Chr 9, 133346876: 133346876
8ASS1NM_000050.4(ASS1): c.773+49C> TSNVPathogenicrs763389916GRCh38Chr 9, 130479849: 130479849
9ASS1NM_000050.4(ASS1): c.323G> T (p.Arg108Leu)SNV, CompoundHeterozygotePathogenicrs35269064GRCh37Chr 9, 133333936: 133333936
10ASS1NM_000050.4(ASS1): c.257G> A (p.Arg86His)SNVPathogenicrs575001023GRCh38Chr 9, 130458483: 130458483
11ASS1NM_000050.4(ASS1): c.851C> T (p.Thr284Ile)SNVPathogenicrs886039853GRCh38Chr 9, 130489345: 130489345
12ASS1NM_000050.4(ASS1): c.970+5G> ASNVPathogenicrs372128852GRCh38Chr 9, 130489469: 130489469
13ASS1NM_000050.4(ASS1): c.1064delA (p.Lys355Argfs)deletionPathogenicrs886043088GRCh37Chr 9, 133370347: 133370347
14ASS1NM_000050.4: c.978delGdeletionLikely pathogenicChr na, -1: -1
15ASS1NM_000050.4: c.412C> TSNVLikely pathogenicChr na, -1: -1
16ASS1NM_000050.4: c.366delGdeletionLikely pathogenicChr na, -1: -1
17ASS1NM_000050.4: c.226delGdeletionLikely pathogenicChr na, -1: -1
18ASS1NM_000050.4: c.3G> ASNVLikely pathogenicChr na, -1: -1
19ASS1NM_000050.4: c.814C> TSNVLikely pathogenicChr na, -1: -1
20ASS1NM_000050.4: c.773+1G> ASNVLikely pathogenicChr na, -1: -1
21ASS1NM_000050.4: c.567-1G> TSNVLikely pathogenicChr na, -1: -1
22ASS1NM_000050.4: c.1127+1G> ASNVLikely pathogenicChr na, -1: -1
23ASS1ASS1, EX5DELdeletionPathogenicChr na, -1: -1
24ASS1ASS1, EX6DELdeletionPathogenicChr na, -1: -1
25ASS1ASS1, IVS6AS, A-G, -2deletionPathogenicChr na, -1: -1
26ASS1NM_000050.4(ASS1): c.40G> A (p.Gly14Ser)SNVPathogenicrs121908636GRCh37Chr 9, 133327655: 133327655
27ASS1NM_000050.4(ASS1): c.470G> A (p.Arg157His)SNVPathogenicrs121908637GRCh37Chr 9, 133342161: 133342161
28ASS1NM_000050.4(ASS1): c.539G> A (p.Ser180Asn)SNVLikely pathogenic, Pathogenicrs121908638GRCh37Chr 9, 133346264: 133346264
29ASS1NM_000050.4(ASS1): c.970G> A (p.Gly324Ser)SNVLikely pathogenic, Pathogenicrs121908639GRCh37Chr 9, 133364851: 133364851
30ASS1NM_000050.4(ASS1): c.1087C> T (p.Arg363Trp)SNVLikely pathogenic, Pathogenicrs121908640GRCh37Chr 9, 133370370: 133370370
31ASS1NM_000050.4(ASS1): c.1168G> A (p.Gly390Arg)SNVPathogenicrs121908641GRCh37Chr 9, 133374932: 133374932
32ASS1NM_000050.4(ASS1): c.910C> T (p.Arg304Trp)SNVPathogenicrs121908642GRCh37Chr 9, 133364791: 133364791
33ASS1NM_000050.4(ASS1): c.53C> T (p.Ser18Leu)SNVPathogenicrs121908643GRCh37Chr 9, 133327668: 133327668
34ASS1NM_000050.4(ASS1): c.256C> T (p.Arg86Cys)SNVPathogenicrs121908644GRCh37Chr 9, 133333869: 133333869
35ASS1NM_000050.4(ASS1): c.835C> T (p.Arg279Ter)SNVLikely pathogenic, Pathogenicrs121908645GRCh37Chr 9, 133355833: 133355833
36ASS1NM_000050.4(ASS1): c.535T> C (p.Trp179Arg)SNVPathogenicrs121908646GRCh37Chr 9, 133346260: 133346260
37ASS1NM_000050.4(ASS1): c.1085G> T (p.Gly362Val)SNVPathogenicrs121908647GRCh37Chr 9, 133370368: 133370368
38ASS1ASS1, IVS6, G-A, +5SNVPathogenicChr na, -1: -1
39ASS1ASS1, IVS15, G-C, -1SNVPathogenicChr na, -1: -1
40ASS1NM_000050.4(ASS1): c.928A> C (p.Lys310Gln)SNVPathogenicrs121908648GRCh37Chr 9, 133364809: 133364809
41ASS1NM_000050.4(ASS1): c.496-2A> GSNVPathogenicrs398123130GRCh38Chr 9, 130470832: 130470832
42ASS1NM_000050.4(ASS1): c.787G> A (p.Val263Met)SNVPathogenicrs192838388GRCh37Chr 9, 133355785: 133355785
43ASS1NM_000050.4(ASS1): c.793C> T (p.Arg265Cys)SNVPathogenicrs148918985GRCh37Chr 9, 133355791: 133355791
44ASS1NM_000050.4(ASS1): c.794G> A (p.Arg265His)SNVLikely pathogenic, Pathogenicrs398123131GRCh37Chr 9, 133355792: 133355792
45ASS1NM_000050.4(ASS1): c.836G> A (p.Arg279Gln)SNVLikely pathogenic, Pathogenicrs371265106GRCh37Chr 9, 133355834: 133355834

Expression for genes affiliated with Citrullinemia

About this section
Search GEO for disease gene expression data for Citrullinemia.

Pathways for genes affiliated with Citrullinemia

About this section

GO Terms for genes affiliated with Citrullinemia

About this section

Biological processes related to Citrullinemia according to GeneCards Suite gene sharing:

(show all 10)
idNameGO IDScoreTop Affiliating Genes
1negative regulation of leukocyte cell-cell adhesionGO:190303810.1ASS1, PPARA
2arginine biosynthetic processGO:000652610.0ASL, ASS1
3arginine biosynthetic process via ornithineGO:00424509.9ASL, OTC
4midgut developmentGO:00074949.8ASS1, OTC
5response to zinc ionGO:00100439.8ASS1, OTC
6response to insulinGO:00328689.8OTC, PPARA
7gluconeogenesisGO:00060949.6PC, SLC25A13
8liver developmentGO:00018899.6ASS1, OTC
9urea cycleGO:00000509.4ASL, ASS1, OTC
10lipid metabolic processGO:00066299.1PC, PPARA

Molecular functions related to Citrullinemia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1amino acid bindingGO:00165979.4ASS1, OTC

Sources for Citrullinemia

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet